Medical Countermeasures New Insights Into Tularemia Pathogen May Inform Next-Generation Medical CountermeasuresGlobal Biodefense StaffMay 14, 2026
Medical Countermeasures When Mpox Strikes the Eye: A Case for Combination Antiviral TherapyGlobal Biodefense StaffApril 16, 2026
Medical Countermeasures Smallpox Preparedness Contracts Top $60 Million as U.S. and International Partners Bolster Biodefense StockpilesGlobal Biodefense StaffMarch 25, 2026
Tekmira Enters Phase II Ebola Clinical Study in Sierra Leone Medical Countermeasures March 11, 2015 …